Compare VERA & VTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | VTLE |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 733.9M |
| IPO Year | 2021 | 2011 |
| Metric | VERA | VTLE |
|---|---|---|
| Price | $51.16 | $17.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 11 |
| Target Price | ★ $67.67 | $25.78 |
| AVG Volume (30 Days) | ★ 1.9M | 601.6K |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,897,003,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.85 |
| 52 Week Low | $18.53 | $12.30 |
| 52 Week High | $51.19 | $36.72 |
| Indicator | VERA | VTLE |
|---|---|---|
| Relative Strength Index (RSI) | 78.40 | 52.95 |
| Support Level | $47.22 | $17.79 |
| Resistance Level | $51.19 | $19.45 |
| Average True Range (ATR) | 3.55 | 0.65 |
| MACD | 0.54 | -0.03 |
| Stochastic Oscillator | 97.47 | 50.64 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Vital Energy is an independent energy company. Its business is focused on the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas. The Company has identified one operating segment: exploration and production.